These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34827582)

  • 1. The Pseudo-Symmetric
    D'Orsi R; Funicello M; Laurita T; Lupattelli P; Berti F; Chiummiento L
    Biomolecules; 2021 Oct; 11(11):. PubMed ID: 34827582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of novel amprenavir-based P1-substituted bi-aryl derivatives as ultra-potent HIV-1 protease inhibitors.
    Yan J; Huang N; Li S; Yang LM; Xing W; Zheng YT; Hu Y
    Bioorg Med Chem Lett; 2012 Mar; 22(5):1976-9. PubMed ID: 22306123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A symmetric inhibitor binds HIV-1 protease asymmetrically.
    Dreyer GB; Boehm JC; Chenera B; DesJarlais RL; Hassell AM; Meek TD; Tomaszek TA; Lewis M
    Biochemistry; 1993 Jan; 32(3):937-47. PubMed ID: 8422397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, and biological and structural evaluations of novel HIV-1 protease inhibitors to combat drug resistance.
    Parai MK; Huggins DJ; Cao H; Nalam MN; Ali A; Schiffer CA; Tidor B; Rana TM
    J Med Chem; 2012 Jul; 55(14):6328-41. PubMed ID: 22708897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation in vitro and in mammalian cells of new heteroaryl carboxyamides as HIV-protease inhibitors.
    Funicello M; Chiummiento L; Tramutola F; Armentano MF; Bisaccia F; Miglionico R; Milella L; Benedetti F; Berti F; Lupattelli P
    Bioorg Med Chem; 2017 Sep; 25(17):4715-4722. PubMed ID: 28739156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and Biological Evaluation of 3,9-Dioxatetraasteranes as C
    Li P; Wang S; Wang H; Yan H
    Biol Pharm Bull; 2019; 42(2):261-267. PubMed ID: 30713256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Piperidine scaffold as the novel P2-ligands in cyclopropyl-containing HIV-1 protease inhibitors: Structure-based design, synthesis, biological evaluation and docking study.
    Zhou H; Zhu M; Ma L; Zhou J; Dong B; Zhang G; Cen S; Wang Y; Wang J
    PLoS One; 2020; 15(7):e0235483. PubMed ID: 32697773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of novel HIV-1 protease inhibitors using tertiary amine as P2-ligands.
    Yang ZH; Bai XG; Zhou L; Wang JX; Liu HT; Wang YC
    Bioorg Med Chem Lett; 2015 May; 25(9):1880-3. PubMed ID: 25838144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enamino-oxindole HIV protease inhibitors.
    Eissenstat M; Guerassina T; Gulnik S; Afonina E; Silva AM; Ludtke D; Yokoe H; Yu B; Erickson J
    Bioorg Med Chem Lett; 2012 Aug; 22(15):5078-83. PubMed ID: 22749283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of highly potent HIV-1 protease inhibitors with novel isosorbide-derived P2 ligands.
    Qiu X; Zhao GD; Tang LQ; Liu ZP
    Bioorg Med Chem Lett; 2014 Jun; 24(11):2465-8. PubMed ID: 24767846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and biological evaluation of HIV-1 protease inhibitors with morpholine derivatives as P2 ligands in combination with cyclopropyl as P1' ligand.
    Dou Y; Zhu M; Dong B; Wang JX; Zhang GN; Zhang F; Wang YC
    Bioorg Med Chem Lett; 2020 Apr; 30(7):127019. PubMed ID: 32057582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, X-ray analysis, and biological evaluation of a new class of stereopure lactam-based HIV-1 protease inhibitors.
    Wu X; Ohrngren P; Joshi AA; Trejos A; Persson M; Arvela RK; Wallberg H; Vrang L; Rosenquist A; Samuelsson BB; Unge J; Larhed M
    J Med Chem; 2012 Mar; 55(6):2724-36. PubMed ID: 22376008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of new simple indolic non peptidic HIV Protease inhibitors: the effect of different substitution patterns.
    Bonini C; Chiummiento L; Di Blasio N; Funicello M; Lupattelli P; Tramutola F; Berti F; Ostric A; Miertus S; Frecer V; Kong DX
    Bioorg Med Chem; 2014 Sep; 22(17):4792-802. PubMed ID: 25074848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of potent C(2)-symmetric, diol-based hiv-1 protease inhibitors. Investigation of thioalkyl and thioaryl P1/P1' substituents.
    Mühlman A; Classon B; Hallberg A; Samuelsson B
    J Med Chem; 2001 Oct; 44(21):3402-6. PubMed ID: 11585445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-based design of potent HIV-1 protease inhibitors with modified P1-biphenyl ligands: synthesis, biological evaluation, and enzyme-inhibitor X-ray structural studies.
    Ghosh AK; Yu X; Osswald HL; Agniswamy J; Wang YF; Amano M; Weber IT; Mitsuya H
    J Med Chem; 2015 Jul; 58(13):5334-43. PubMed ID: 26107245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New heteroaryl carbamates: Synthesis and biological screening in vitro and in mammalian cells of wild-type and mutant HIV-protease inhibitors.
    Tramutola F; Armentano MF; Berti F; Chiummiento L; Lupattelli P; D'Orsi R; Miglionico R; Milella L; Bisaccia F; Funicello M
    Bioorg Med Chem; 2019 May; 27(9):1863-1870. PubMed ID: 30922618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and Synthesis of Potent HIV-1 Protease Inhibitors Containing Bicyclic Oxazolidinone Scaffold as the P2 Ligands: Structure-Activity Studies and Biological and X-ray Structural Studies.
    Ghosh AK; Williams JN; Ho RY; Simpson HM; Hattori SI; Hayashi H; Agniswamy J; Wang YF; Weber IT; Mitsuya H
    J Med Chem; 2018 Nov; 61(21):9722-9737. PubMed ID: 30354121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent HIV protease inhibitors containing a novel (hydroxyethyl)amide isostere.
    Beaulieu PL; Wernic D; Abraham A; Anderson PC; Bogri T; Bousquet Y; Croteau G; Guse I; Lamarre D; Liard F; Paris W; Thibeault D; Pav S; Tong L
    J Med Chem; 1997 Jul; 40(14):2164-76. PubMed ID: 9216835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular docking and 3D-QSAR studies of HIV-1 protease inhibitors.
    Khedkar VM; Ambre PK; Verma J; Shaikh MS; Pissurlenkar RR; Coutinho EC
    J Mol Model; 2010 Jul; 16(7):1251-68. PubMed ID: 20069323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, protein-ligand X-ray structure, and biological evaluation of a series of novel macrocyclic human immunodeficiency virus-1 protease inhibitors to combat drug resistance.
    Ghosh AK; Kulkarni S; Anderson DD; Hong L; Baldridge A; Wang YF; Chumanevich AA; Kovalevsky AY; Tojo Y; Amano M; Koh Y; Tang J; Weber IT; Mitsuya H
    J Med Chem; 2009 Dec; 52(23):7689-705. PubMed ID: 19746963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.